- Home
- CRT vs NTRB Comparison
CRT vs NTRB Comparison
Compare CRT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRT | NTRB |
|---|---|---|
| Founded | 1991 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.5M | 71.7M |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRT | NTRB |
|---|---|---|
| Price | $7.89 | $4.53 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 25.4K | 22.3K |
| Earning Date | 03-12-2026 | 12-11-2025 |
| Dividend Yield | ★ 9.36% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $5,621,913.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $10.68 | ★ N/A |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $7.07 | $3.72 |
| 52 Week High | $13.31 | $11.78 |
Technical Indicators
Market Signals| Indicator | CRT | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 40.12 |
| Support Level | $7.34 | $4.35 |
| Resistance Level | $8.27 | $4.77 |
| Average True Range (ATR) | 0.31 | 0.42 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 36.99 | 20.66 |
Price Performance
Historical ComparisonAbout CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.